Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Oct 15;10(10):2544-2546.
doi: 10.18632/aging.101598.

Mutant ubiquitin reduces Aβ plaques

Affiliations
Editorial

Mutant ubiquitin reduces Aβ plaques

Bert M Verheijen et al. Aging (Albany NY). .
No abstract available

Keywords: Alzheimer’s disease; Aβ plaques; amyloid β; mutant ubiquitin; proteostasis; ubiquitin-proteasome system; γ-secretase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mutant ubiquitin (UBB+1) reduces Aβ plaques in APPPS1 mice. (A) Schematic diagram of amyloid precursor protein (APP) processing leading to Aβ. (B) γ-secretase is a multimeric enzyme complex that cleaves APP C-terminal fragment (CTF) to produce Aβ and an APP intracellular domain (AICD). (C) Transgenic APPPS1 mice carry two mutations that represent early-onset AD and develop age-related amyloid plaque pathology. (D) In APPPS1xUBB+1 mice, APP CTF-β levels are reduced and γ-secretase function is partially restored. (E) Besides secretases, alternate protein degradation pathways have been reported to degrade APP and Aβ.

Comment on

References

    1. Hardy J, Selkoe DJ. Science. 2002; 297:353–56. 10.1126/science.1072994 - DOI - PubMed
    1. van Leeuwen FW, et al. Science. 1998; 279:242–47. 10.1126/science.279.5348.242 - DOI - PubMed
    1. Fischer DF, et al. Neurobiol Aging. 2009; 30:847–63. 10.1016/j.neurobiolaging.2008.06.009 - DOI - PubMed
    1. van Tijn P, et al. Neurochem Int. 2012; 61:739–48. 10.1016/j.neuint.2012.07.007 - DOI - PubMed
    1. Verheijen BM, et al. Neurobiol Aging. 2018; 72:62–71. 10.1016/j.neurobiolaging.2018.08.011 - DOI - PubMed